Therefore, to further substantiate the potential crosstalk roles of p38 in the pathogenesis of this depression model, we first blocked p38 MAPK activity with the use of its specific inhibitor, SB203580, during CUMS exposure. This evidence concerns the gene MAPK14 and depressive symptom measurement.